ICMAR launch India’s first large-scale trial for two new TB vaccines – VPM1002 and Immuvac

The Indian Council of Medical Research (ICMR) has launched India’s first large-scale trial for two new TB vaccines – VPM1002 and Immuvac. The initiative would enroll 12,000 healthy household contacts of a patient whose sputum has tested positive for TB ..

India signs loan agreement with World Bank to eliminate TB

India has signed a loan agreement worth $400 million with the World Bank (WB) to help treat and eliminate Tuberculosis from the country. In India, around five lakh people died every year due to Tuberculosis. According to Finance Ministry, the ..

2019 World Tuberculosis Day (WTD)

The World Tuberculosis Day (WTD) is observed every year on 24th March to raise public awareness about the devastating health, social and economic consequences of TB, and to step up efforts to end the global TB epidemic. The date marks ..

Sree Chitra Tirunal Institute develops an anti cancer anti-inflamatory drug conjugated to human serum Albumin

The Sree Chitra Tirunal Institute of Medical Sciences and Technology (SCTIMST) has recently developed an anti cancer anti-inflamatory drug conjugated to the human serum Albumin. It is an intravenous delivery system, enabling 100 fold increase in drug bio-availability and is ..

India makes alliance with US to eliminate TB

India has made alliance with United States in public and private sectors to combat the menace of Tuberculosis (TB). The formation of ‘USAID-India End TB Alliance’ was formally announced by the US Agency for International Development (USAID) administrator Mark Green ..

National Anti-TB Drug Resistance Survey

In March, 2018, the Union Health Ministry has released the National Anti-TB Drug Resistance Survey report. The findings of the report include: India which is home to 2.8 million TB patients, the largest in the world of which over a ..